Advances in single-cell technologies have revealed vast differences between cells once thought to be in the same category, calling into question how we define cell type in the first place.
Meet some of the people featured in the November 2017 issue of The Scientist.
Recent advances in single-cell omics and other techniques are revealing variation at genomic, epigenomic, transcriptomic, and posttranscriptomic levels.
A four-time winner of the USA Memory Championship is helping scientists understand how the brain works.
These insect transplants have the potential to wreak economic havoc by outcompeting native insects and destroying crops.
No two neurons are alike. What does that mean for brain function?
With the arrival of a new class of single-nucleotide editors, researchers can target the most common type of pathogenic SNP in humans.
Scientists extend the capabilities of the CRISPR-Cas system to include precise manipulations of RNA sequences in human cells.
Researchers identify 72 novel genetic variants associated with breast cancer risk.
Professionals in the genetics field generally support editing the genomes of somatic cells, mirroring public opinion, but diverge from nonexperts when it comes to germline editing.
The nationwide experiment will initially include around 100,000 volunteers.
After implantation, the tissue developed blood vessels and became integrated into neuronal networks in the animals’ brains.
Researchers deliver small interfering RNAs loaded into nanoparticles into the ears of adult guinea pigs to regenerate hair cells damaged by noise.
The US Senate narrowly approved the politician, who does not have a science background.
© 1986-2018 The Scientist
